X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
Globe Newswire•08/10/2026•07:00 ET
0
Key Highlights
- ➤$150 million senior secured term loan facility replaces X4’s prior loan agreement
- ➤$80 million funded at closing repaid $75 million principal plus related fees
- ➤Additional $70 million available subject to K2HV approval and other conditions
- ➤Phase 3 4WARD enrollment expected by year-end 2026; topline data in H1 2028
Expert Statements
David Kirske, Chief Financial Officer of X4 Pharmaceuticals
“Our partnership with K2 HealthVentures strengthens our capital position and gives us a solid financial foundation as we advance mavorixafor toward potential FDA approval and a commercial launch in chronic neutropenia”
David Kirske, Chief Financial Officer of X4 Pharmaceuticals
“The new structure provides additional flexibility on more favorable terms and is aligned with our strategic priorities.”
David Kirske, Chief Financial Officer of X4 Pharmaceuticals
“We expect to reach several key milestones in the near term, including completing enrollment in our Phase 3 4WARD trial this year and reporting topline results in the first half of 2028.”
David Kirske, Chief Financial Officer of X4 Pharmaceuticals
“We are executing with focus, discipline, and a clear line of sight to what matters most.”
Parag Shah, Founding Managing Director and Chief Executive Officer of K2 HealthVentures
“We are pleased to partner with X4 Pharmaceuticals as it advances mavorixafor for the potential treatment of people living with rare hematology diseases.”
Parag Shah, Founding Managing Director and Chief Executive Officer of K2 HealthVentures
“This financing reflects our strategy of serving as a long-term financing partner to innovative life sciences companies, and we look forward to supporting X4’s next phase of growth.”
- Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities -
- Expect Completion of Enrollment in Phase 3 4WARD trial by Year-End 2026 and Topline Data in H1 2028 -
Get started
Create a free account to read the full story.